Xconomy | San Diego - Business + Technology in the Exponential Economy

Biotech, people, Stem Cells

Novocell Hires John West as CEO

Luke Timmerman 5/11/09

Novocell, the San Diego-based developer of stem cell therapies for diabetes, said it has named John West as president, CEO , and a member of its board. West was previously CEO of Solexa, a maker of genome sequencing machines that was sold to San Diego-based Illumina (NASDAQ: ILMN) in 2007 for more than $600 million.

Luke Timmerman is the National Biotechnology Editor for Xconomy. You can e-mail him at ltimmerman@xconomy.com, call 206-624-2374, or follow him on Twitter at http://twitter.com/ldtimmerman.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.